Titre:
  • Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome.
Auteur:Roufosse, Florence; Butterfield, Joseph H; Steinfeld, Jonathan; Bentley, Jane J.H.; von Maltzahn, Robyn; Kwon, Namhee; Nelsen, Linda
Informations sur la publication:Frontiers in Medicine, 10, page (1035250)
Statut de publication:Publié, 2023-01-01
Sujet CREF:Médecine pathologie humaine
Mots-clés:HES-DS
daily symptoms
hypereosinophilic syndrome (HES)
mepolizumab
most bothersome
patient-reported
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2296-858X
info:doi/10.3389/fmed.2023.1035250
info:scp/85153372648
info:pmid/37064032
PMC10090544